Molecular Partners Presents Positive Preclinical Data for First Switch-DARPin Candidate MP0621 at EHA 2024
GlobeNewswire
· Proof-of-concept of Switch-DARPin platform established in vivo, enabling the use of logic-gated and reversible immune..